# KannaLife Sciences, Inc.: Form D filings

KannaLife Sciences, Inc., a pharmaceuticals company in West Hills, NY, filed 2 Form D notices with the SEC between 2012 and 2013. The latest, on April 30, 2013, reports $1.5 million sold of a $1.5 million offering to 2 investors.

Find out what KannaLife Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20KannaLife%20Sciences%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=KannaLife%20Sciences%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fkannalife-sciences-inc-1538856)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20KannaLife%20Sciences%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=KannaLife%20Sciences%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fkannalife-sciences-inc-1538856)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 363 West Hills Road, West Hills, NY, 11743
- Phone: (516) 669-3219
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2010
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1538856

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 30, 2013 | New notice | $1,500,000 | $1,500,000 | $0 | 2 | Mar 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1538856/000153885613000001/0001538856-13-000001-index.htm) |
| Feb 3, 2012 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1538856/000153885612000001/0001538856-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michael Mona, Jr. | Director |  |
| Mark Corrao | Executive Officer |  |
| Dean Petkanas | Executive Officer, Director |  |
| Stuart Titus | Director |  |
| Thoma Kikis | Executive Officer, Director |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Apr 29, 2013](https://specstream.ai/data/form-d/week/2013-04-29) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what KannaLife Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).